Retatrutide for Sale Online 2026: $10.00 vs $9.75 per mg
Retatrutide is still investigational in 2026, so online listings are research powder. At catalog pricing a 10 mg vial runs $10.00/mg, 20 mg $9.75/mg.
Retatrutide for sale online in 2026 means research-grade lyophilized powder from chemical suppliers, not a pharmacy product. Retatrutide (LY3437943) is still investigational, and the patient-facing route on record is pre-approval single-patient expanded access for adults with a BMI of at least 35 kg/m² and two or more serious obesity-related complications who are refractory to the best approved therapy. Every listing you find is therefore priced per milligram of powder, and the per-mg figure rather than the sticker price is what separates them. Prices as of September 2026 from the HEEZ catalog work out to $10.00/mg for a 10 mg vial and $9.75/mg for a 20 mg vial.
Why is retatrutide still research-only in 2026?
That expanded-access record is the tell. A compound with an approved label does not route single patients through expanded access, and a supplier cannot sell an approved drug as a bench reagent. What online vendors ship is bulk synthesized peptide under a research-use-only designation, which is why every result for retatrutide for sale online 2026 is a chemical supplier rather than a pharmacy.
Two consequences follow for anyone comparing listings. There is no monograph fixing what belongs in the vial, and there is no regulator auditing the purity claim printed next to the price. Both live on the seller’s certificate of analysis or nowhere.
Naming is the other 2026 wrinkle. The same molecule appears on listings as retatrutide, as LY3437943, as “Reta”, and as “GLP-3”, the last being vendor shorthand for the triple agonist rather than a published designation. Searching one of those names and not the others hides listings for identical material.
What does retatrutide cost per mg online?
Sticker price tracks vial size, so the only number that compares across listings is cost per milligram: vial price divided by labeled milligrams.
| Vial size (mg) | Price (USD) | Cost per mg (USD) | Arithmetic |
|---|---|---|---|
| 10 | 100 | 10.00 | 100 ÷ 10 |
| 20 | 195 | 9.75 | 195 ÷ 20 |
Cost per milligram at the two retatrutide denominations carried, computed as vial price ÷ labeled milligrams. Prices as of September 2026 from the HEEZ catalog.
The spread is $0.25/mg, which is 2.5% of the 10 mg rate ($0.25 ÷ $10.00). Buying 20 mg as two 10 mg vials costs $200; buying the same 20 mg as one vial costs $195. The $5 gap is exactly 20 mg × $0.25.
A 2.5% break is smaller than the discount most bulk pricing trains you to expect, and the reason is worth stating plainly: the peptide is a minority of the cost of a filled, stoppered, lyophilized vial. Doubling the powder does not double the price of the glass, the crimp cap, the fill run, or the shipment.
Is the bigger vial always the better buy?
Per milligram, yes at these two sizes. Per experiment, not automatically. One 20 mg vial is a single reconstitution event and a single stopper punctured repeatedly, while two 10 mg vials split that exposure across two sealed units. Work through material slowly and the $5 saved buys a longer in-solution life for the back half of the powder.
Fill geometry decides whether the trade is real, and how headspace on a vial listing reads is the field that tells you whether the 20 mg vial is the same glass as the 10 mg one with more powder in it or a genuinely larger format.
Shipping is the variable that does not scale with vial size at all. Listings commonly describe lyophilized retatrutide as shelf-stable in transit without a cold chain, and storage temperature expectations shift once the vial is reconstituted rather than while it is still a sealed powder.
What do the published dose arms say about vial sizes?
The reason 10 mg and 20 mg are the common denominations, rather than 1 mg or 250 mg, traces back to the quantities the trial program actually consumed.
| Weekly dose arm | Body-weight change at 24 weeks |
|---|---|
| Placebo | −1.6% |
| 1 mg | −7.2% |
| 4 mg (combined) | −12.9% |
| 8 mg (combined) | −17.3% |
| 12 mg | −17.5% |
Least-squares mean percent change in body weight from baseline to 24 weeks, the primary endpoint of a phase 2 randomized, double-blind, placebo-controlled trial in 338 adults dosed subcutaneously once weekly for 48 weeks. Source: the 2023 NEJM retatrutide phase 2 obesity trial report.
Within that single trial, the gap between the combined 8 mg arms and the 12 mg arm is 17.5 − 17.3 = 0.2 percentage points, against 17.3 − 12.9 = 4.4 points between 4 mg and 8 mg. The curve flattens above 8 mg.
Now run the supply arithmetic on the top arm. Once-weekly 12 mg across the trial’s 48 weeks is 12 × 48 = 576 mg per participant. At 20 mg per vial that is 576 ÷ 20 = 28.8 vials, so 29 vials holding 580 mg, at $195 each for $5,655 (prices as of September 2026 from the HEEZ catalog). The 4 mg left over in vial 29 is worth $39 at $9.75/mg. Quantities on that order are why vendors bother listing 30 mg and 60 mg formats and 100-vial wholesale tiers at all.
What has to be on a 2026 listing before the price is comparable?
A per-mg figure only compares if both listings mean the same thing by “mg”. Five fields decide that:
- Purity method named, not just a percentage. “99%” with no method disclosed is a weaker claim than 99% by RP-HPLC with the main-peak retention time given.
- A lot number on the COA matching the lot printed on the vial. A single COA reused across batches documents a different vial than the one in the box.
- Net peptide content stated separately from HPLC purity. Purity is a ratio between chromatographic peaks; net peptide is how much of the labeled milligram amount is peptide rather than water, salt, and counter-ions.
- Mass spectrometry identity against the theoretical mass, so the purity figure is known to have been run on retatrutide and not on a near-neighbour analog.
- Endotoxin and sterility results, which are separate assays and are not implied by any purity number.
Working a real document through in that order is covered in reading a batch COA line by line. Everything offered under retatrutide for sale online is supplied for laboratory research use only, and the COA is the only paper in the transaction carrying measured values instead of claims.
Net peptide content is the field that moves the effective per-mg cost after the money is already spent. Divide the vial price by the net peptide milligrams instead of the labeled milligrams, and a $100 10 mg vial (prices as of September 2026 from the HEEZ catalog) stops being $10.00/mg the moment a COA reports net peptide under 100%.
A note on how to read this
This article is written for research and educational reference. The materials described are sold for laboratory research and are not for human consumption. Nothing here is dosing guidance, a prescription, or a clinical recommendation.